Point of Byetta Study? Warning is Still Needed

July 13th, 2010. By

Rose Colored Glasses Point of Byetta Study? Warning is Still NeededDespite a recent study that puts into question the link between Byetta and pancreatitis, I was looking back over Byetta’s history as it relates to FDA labelling. For some background, Byetta came on the market in 2005—to treat patients with type-2 diabetes—and some reports indicate that over 10 million Byetta prescriptions have been written since 2005.

But since 2005, there have been some other interesting (or should I say “disturbing”) developments with Byetta as well. According to the FDA, between April 28, 2005 and December 31, 2006, there were 30 domestic reports of acute pancreatitis in patients who were taking exenatide (the generic name for Byetta). Clearly feeling that thirty such cases within the span of just under two years was perhaps worth raising an eyebrow, the FDA responded with some additional Byetta warnings. Here’s what happened:

October, 2007: the FDA mandated that Amylin and Eli Lilly include stricter, more prominent warning labels about possible Byetta side effects on Byetta’s packaging; the new Byetta warnings included acute pancreatitis.

August, 2008: the FDA issued an alert to healthcare providers regarding six additional cases of necrotizing or hemorrhagic pancreatitis among Byetta patients. Two of those six cases resulted in death.

November, 2009: Between April, 2005 and October, 2008, the FDA had received 78 reports of problems with kidney function in patients using Byetta. Some cases occurred in patients with pre-existing kidney disease or in patients with one or more risk factors for developing kidney problems. Based on this, the FDA issued new safety information on Byetta to include a warning of possible kidney function problems a a side effect.

Now, while I surely don’t believe the FDA is incapable of error or misjudgement (we only have to look to Avandia this week to question such), it does seem that when the number of reports hitting the FDA’s AERS database rises above double digits in a fairly short amount of time that one should take pause. And this latest study—which basically found that the risk of acute pancreatitis is no greater with Byetta than other diabetes drugs in its class and that diabetics are more prone to such—seems a bit like saying well, we know that Budweiser beer (and no, I’m not picking on Budweiser—consider it a fine job of brand name retention tactics from their marketing team) can get you drunk like other beers, so what’s the problem if I down a 12-pack of Bud or of Coors? The fact that something is no worse than something in its class doesn’t quite absolve it in my book. The hangover stills greets you in the morning.

Another thing I’m not loving about this latest Byetta study is that it was not done as a randomized clinical trial—it was done via observation. Observation of Medco’s (yes, the pharmacy benefit management company whose prescription card you may well be carrying in your wallet) pharmacy and medical claims data. So the population was a rather non-random bunch. And, I might add that while there were declarations of there being no incentive etc etc, Byetta is one of the covered brand-name drugs on Medco’s standard formulary list—which as Reuters points out is the “list of preferred drugs.”

Call me jaded, but I’d like an independent source to conduct a clinical trial on this. I’m certainly happy for all the Byetta patients out there if there is ultimately no real measurable correlation between Byetta and pancreatitis and kidney problems. That would good news. But unfortunately I left my rose-colored glasses at the beach last weekend.

4 Responses to “Point of Byetta Study? Warning is Still Needed”

  1. July 23rd, 2010 at 4:50 pm carmen Says:

    very insightful i just started taking Byetta but after reading this not sure if I want to continue. But as you said it basically has the same side effect as all the other meds so my question is, am I better off taking meds or having my sugar level high? I honestly felt ok I went to doc one day and was told I was diabetic gave me Janumet and to me that was the worst I coughed for a whole year and when I say cough it was very bad, to the point that I would vomit.

    [Reply]

    admin Reply:

    Hi Carmen, I wish I could provide a more definitive answer to your question, but the answer really needs to come out of an open and frank discussion with your physician regarding the pros and cons of taking a prescription medication for diabetes (and which one), or not. Unfortunately, it's not always a straightforward answer… Regarding Byetta, I would certainly discuss the risks for side effects with your doctor, and be mindful of any side effects you may be experiencing.

    [Reply]

    admin Reply:

    Hi Carmen, I wish I could provide a more definitive answer to your question, but the answer really needs to come out of an open and frank discussion with your physician regarding the pros and cons of taking a prescription medication for diabetes (and which one), or not. Unfortunately, it's not always a straightforward answer… Regarding Byetta, I would certainly discuss the risks for side effects with your doctor, and be mindful of any side effects you may be experiencing.

    [Reply]

  2. September 27th, 2010 at 10:35 am Christine D Says:

    I am posting this on behalf of my sister. She was recently diagnosed with serious lung ailments we believe may be caused by Byetta. After a biopsy, she was diagnosed with Hypersensitivity pneumonitis and several other serious lung ailments. Her doctors are baffled. Her symptoms were a very bad cough that began soon after starting the medication, a reaction akin to a bee bite at the injection site that cleared up after changing needle size, fatigue and weight loss.

    The reason we believe it is linked to the Byetta is due to the timing of her symptoms and finding mention of Hypersensitivity pneumonitis on the Byetta website under Adverse Reactions. http://pi.lilly.com/us/byetta-pi.pdf

    I think further study of this drug is needed!

    [Reply]

    admin Reply:

    Hi Christine, Thank you for sharing what’s going on with your sister. Byetta has been linked to some pretty serious side effects, and there are currently some Byetta lawsuits going on. I’ve sent you an email with some more information (check your spam folder in case it may have been filtered!); there is more Byetta information on our website, as well as a claim form to submit for a lawyer to review the details of your sister’s case. I truly wish your sister renewed health and a speedy recovery.

    [Reply]

    admin Reply:

    Hi Christine, Thank you for sharing what’s going on with your sister. Byetta has been linked to some pretty serious side effects, and there are currently some Byetta lawsuits going on. I’ve sent you an email with some more information (check your spam folder in case it may have been filtered!); there is more Byetta information on our website, as well as a claim form to submit for a lawyer to review the details of your sister’s case. I truly wish your sister renewed health and a speedy recovery.

    [Reply]

Leave a Reply

Legal Help Now
Popular Categories
Lawyers Giving BackAsbestos News RoundupPleading IgnoranceTotally Tortelicious
Archive by Category
Tags
Asbestos asbestosis asbestos lawsuit Asbestos Mesothelioma Asbestos Settlement asbestos_mesothelioma Avandia Bank of America BP BP Oil Spill California labor law chinese drywall Class Action Class Action Lawsuit Consumer Fraud Discrimination Employment Facebook false advertising FDA GlaxoSmithKline GSK Lawyers Giving Back medical malpractice Merck mesothelioma Overdraft fees Overtime Pay paxil Pfizer Pleading Ignorance Pro Bono Prozac Reglan Securities Fraud Seroquel Settlement SSRI Tortelicious Toyota Veterans Wal-Mart Week Adjourned Yasmin Yaz
Links
  • Legal Juice
  • Marketing Strategy and the Law
  • MyFoodPoisoningLawyer
  • WSJ Law Blog
  • Share this Page
    RSS Feed
    |
    Free Delivery
    Find us on
    Find us on FacebookFind us on LinkedInFind us on Foursquare Follow us on Twitter
    Polls

    The U.S. Supreme Court adds state-mandated racial diversity and affirmative action in college admissions to its docket. Should race be a factor in college admissions?

    View Results

    Loading ... Loading ...
    Better Business Bureau

    Best of the Web Approved
    Visit our Zazzle Store